Austria awards €1.2 million for hypertension vaccine development
This article was originally published in Scrip
Executive Summary
Austria's research promotion agency, the FFG, has given the local biotech company Affiris a €1.2 million grant for the development of a vaccine against hypertension, which the company believes may become the first vaccine developed against a human hormone.